I'm assuming market is reacting to Feb sales, but weather was presumably a factor. Inventory growth was much lower than sales both for the quarter and year over year (given seasonal trends the latter is more relevant). They are expecting significant inventory growth this year due to addition of higher quality SKU's, but they claim customers have been asking for these products, so this would then be a plus. Lack of further international expansion is a bit disappointing. A special dividend is likely this year given cash on hand, but I know of a smaller, less traded company which has done buybacks.
That is strange as I am still having the problem, for example with TLF today. At one time Yahoo permitted some tailoring of news items you would see by source, but I cannot find that option anymore. Anyway, thanks for responding.
Relevant, but not explanatory, is that latest data on consumer expenditures shows that healthcare took a jump in January, which WSJ attributes to Obamacare, although expectation is that size of jump will moderate: some people would have put off elective expenditures until they got health insurance.
I've noticed that when using Yahoo portfolios, they no longer show company press releases! if you click on a particular stock in the portfolio, you then see the press releases but this is not acceptable. Does anyone have a better site for the purpose of tracking news?
What complacency. Their target return on capital is only 9%, they don't expect to meet it this year even excluding sugar, and they think they are doing a great job. Hopefully, they are being conservative, it does sound like that. 200 million buyback is all they can muster? I think the whole problem starts with the return on capital goal, for the entire industry.
Why is he still CEO? Two failed US chiefs. Initiatives which consistently fail. Worst of all is that they claim items like wings were test marketed: I suspect they were so desperate to reverse sales trends they either hurried test, or employees now tell management what they want to hear. MCD needs realistic goals, and managers who are not slogan oriented.
The Food and Drug Administration (FDA) is implementing a voluntary plan with industry to phase out the use of certain antibiotics for enhanced food production.
Is this one reason for recent ODC price rise as it makes the AMLAN products (see annual meeting slides) more important?
Viking, If you know how to edit out typo's after a message is posted, I am all ears. It is not like Amazon book reviews which can be edited.
Doesn't a lot have to do with what your competitors are doing and how sensitive your product pricing is to natural gas prices? If it is insensitive (both up and down), hedging is called for.
EW seems to have a promising future, but: their projection of $3.00 has large volatility subject to when competition emerges during the year. What does this mean for 2015 when they have the competition for the full year?
Biblio, When a company keeps talking of input cost increases in explaining earnings performance, doesn't it suggest they don't have much pricing power, rather than it is thinking long term? Good Katrina anecdote. Sorry I confused you with Burn-in in my last post.
CASEY is earning significant eps from RIN credits, which are likely to go away or drop substantially I would think. Are competitors also earning them, and consequently how well will margins hold up if/when RIN disappears? I wish there were some discussion on the CC.